Skip to content

Taiwan ED Airway Quality Surveillance Registry (TEAR)

The Taiwan ED Airway Quality Surveillance Registry (TEAR): A Prospective Multicenter Observational Study

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07574450
Enrollment
1200
Registered
2026-05-08
Start date
2026-08-01
Completion date
2029-12-01
Last updated
2026-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Airway Management, Emergency Department, Peri-intubation Adverse Events, Tracheal Intubation

Keywords

first-pass success, hypoxemia, hypotension, cardiac arrest, registry

Brief summary

This prospective, multicenter observational registry systematically captures all emergency department tracheal intubations across participating hospitals in Taiwan. The registry focuses on process quality indicators, including first-pass success, and patient-safety outcomes, including hypoxemia, hypotension, and peri-intubation cardiac arrest within 30 minutes of intubation. Routinely generated laboratory and physiologic variables are also collected to improve risk stratification and identify predictors of major adverse events. The study is non-interventional and does not alter clinical care.

Interventions

None listed

Sponsors

Chang Gung Memorial Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Undergoing tracheal intubation in the emergency department during the study period

Exclusion criteria

* Prehospital intubation; intubation performed solely for elective anesthesia/procedural sedation outside emergency indications

Design outcomes

Primary

MeasureTime frameDescription
Incidence of major adverse peri-intubation events within 30 minutes after the start of intubationPeriprocedural, through 30 minutes after the start of intubationsevere hypoxemia, severe hypotension/cardiovascular instability, or cardiac arrest.

Secondary

MeasureTime frame
First-pass successPeriprocedural
In-hospital mortalityFrom intubation to hospital discharge, assessed up to 90 days

Countries

Taiwan

Contacts

CONTACTTING HAO YANG, Doctor
mr2434@cgmh.org.tw+886978989007

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 9, 2026